Global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.
Highlighted with 86 tables and 91 figures, this 178-page report “Global Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Region.
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Products
o Probiotics
o Prebiotics
o Vitamins & Supplements
• Testing Services
o Nutrigenomics Clinical Testing
o Nutrigenomics Research Testing
Based on Test Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Next-generation Sequencing
• Real-time PCR
• DNA Microarray
• Sanger Sequencing
By Test Sample, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Buccal Swab Sample
• Saliva Sample
• Blood Sample
• Other Samples
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Women’s Health
• Metabolic Disorders
• Immune Health
• Cancer Research
• Cardiovascular Diseases
• Diabetes
• Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Nutrition Clinics
• Diagnostics Laboratories
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Offering，Application and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 36
2.4 Emerging Opportunities and Market Trends 39
2.5 Porter’s Fiver Forces Analysis 43
3 Segmentation of Global Market by Offering 47
3.1 Market Overview by Offering 47
3.2 Products 49
3.3.1 Probiotics 50
3.3.2 Prebiotics 51
3.3.3 Vitamins & Supplements 52
3.3 Testing Services 53
3.3.1 Nutrigenomics Clinical Testing 54
3.3.2 Nutrigenomics Research Testing 55
4 Segmentation of Global Market by Test Technology 56
4.1 Market Overview by Test Technology 56
4.2 Next-generation Sequencing 58
4.3 Real-time PCR 59
4.4 DNA Microarray 60
4.5 Sanger Sequencing 61
5 Segmentation of Global Market by Test Sample 62
5.1 Market Overview by Test Sample 62
5.2 Buccal Swab Sample 64
5.3 Saliva Sample 65
5.4 Blood Sample 66
5.5 Other Samples 67
6 Segmentation of Global Market by Application 68
6.1 Market Overview by Application 68
6.2 Women’s Health 70
6.3 Metabolic Disorders 71
6.4 Immune Health 72
6.5 Cancer Research 73
6.6 Cardiovascular Diseases 74
6.7 Diabetes 75
6.8 Other Applications 76
7 Segmentation of Global Market by End User 77
7.1 Market Overview by End User 77
7.2 Hospitals 79
7.3 Nutrition Clinics 80
7.4 Diagnostics Laboratories 81
7.5 Other End Users 82
8 Segmentation of Global Market by Region 83
8.1 Geographic Market Overview 2021-2031 83
8.2 North America Market 2021-2031 by Country 87
8.2.1 Overview of North America Market 87
8.2.2 U.S. 91
8.2.3 Canada 94
8.2.4 Mexico 96
8.3 European Market 2021-2031 by Country 98
8.3.1 Overview of European Market 98
8.3.2 Germany 102
8.3.3 U.K. 104
8.3.4 France 106
8.3.5 Spain 108
8.3.6 Italy 110
8.3.7 Netherlands 112
8.3.8 Rest of European Market 114
8.4 Asia-Pacific Market 2021-2031 by Country 116
8.4.1 Overview of Asia-Pacific Market 116
8.4.2 Japan 120
8.4.3 China 123
8.4.4 Australia 125
8.4.5 India 127
8.4.6 South Korea 129
8.4.7 Rest of APAC Region 131
8.5 South America Market 2021-2031 by Country 133
8.5.1 Argentina 136
8.5.2 Brazil 138
8.5.3 Chile 140
8.5.4 Rest of South America Market 142
8.6 MEA Market 2021-2031 by Country 143
8.6.1 UAE 146
8.6.2 Saudi Arabia 148
8.6.3 South Africa 150
8.6.4 Other National Markets 152
9 Competitive Landscape 153
9.1 Overview of Key Vendors 153
9.2 New Product Launch, Partnership, Investment, and M&A 157
9.3 Company Profiles 158
BASF SE 158
BioGaia 160
Cell Logic 161
Cura Integrative Medicine 162
DNAfit 163
DuPont de Nemours, Inc. 164
Garden of Life, LLC 165
GeneOmbio 166
Genova Diagnostics, Inc. 167
GX Sciences, Inc. 168
Ingredion Incorporated 169
Jarrow Formulas Inc. 170
Koninklijke DSM N.V. 171
MedGenome 172
Metagenics, Inc. 173
Nutrigenomix Inc. 174
Unilever Group 175
XCODE Life 176
Yakult Honsha Co., Ltd. 177
RELATED REPORTS 178
List of Tables:
Table 1. Snapshot of Global Nutrigenomics Market in Balanced Perspective, 2021-2031 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. World Health Spending by Region, $ bn, 2013-2020 35
Table 5. Main Product Trends and Market Opportunities in Global Nutrigenomics Market 39
Table 6. Global Nutrigenomics Market by Offering, 2021-2031, $ mn 47
Table 7. Global Nutrigenomics Market: Products by Type, 2021-2031, $ mn 49
Table 8. Global Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn 53
Table 9. Global Nutrigenomics Market by Test Technology, 2021-2031, $ mn 56
Table 10. Global Nutrigenomics Market by Test Sample, 2021-2031, $ mn 62
Table 11. Global Nutrigenomics Market by Application, 2021-2031, $ mn 68
Table 12. Global Nutrigenomics Market by End User, 2021-2031, $ mn 77
Table 13. Global Nutrigenomics Market by Region, 2021-2031, $ mn 84
Table 14. Leading National Nutrigenomics Market, 2021 and 2031, $ mn 86
Table 15. North America Nutrigenomics Market by Country, 2021-2031, $ mn 89
Table 16. U.S. Nutrigenomics Market by Offering, 2021-2031, $ mn 93
Table 17. U.S. Nutrigenomics Market by Application, 2021-2031, $ mn 93
Table 18. U.S. Nutrigenomics Market by End User, 2021-2031, $ mn 93
Table 19. Canada Nutrigenomics Market by Offering, 2021-2031, $ mn 95
Table 20. Canada Nutrigenomics Market by Application, 2021-2031, $ mn 95
Table 21. Canada Nutrigenomics Market by End User, 2021-2031, $ mn 95
Table 22. Mexico Nutrigenomics Market by Offering, 2021-2031, $ mn 97
Table 23. Mexico Nutrigenomics Market by Application, 2021-2031, $ mn 97
Table 24. Mexico Nutrigenomics Market by End User, 2021-2031, $ mn 97
Table 25. Europe Nutrigenomics Market by Country, 2021-2031, $ mn 101
Table 26. Germany Nutrigenomics Market by Offering, 2021-2031, $ mn 103
Table 27. Germany Nutrigenomics Market by Application, 2021-2031, $ mn 103
Table 28. Germany Nutrigenomics Market by End User, 2021-2031, $ mn 103
Table 29. U.K. Nutrigenomics Market by Offering, 2021-2031, $ mn 105
Table 30. U.K. Nutrigenomics Market by Application, 2021-2031, $ mn 105
Table 31. U.K. Nutrigenomics Market by End User, 2021-2031, $ mn 105
Table 32. France Nutrigenomics Market by Offering, 2021-2031, $ mn 107
Table 33. France Nutrigenomics Market by Application, 2021-2031, $ mn 107
Table 34. France Nutrigenomics Market by End User, 2021-2031, $ mn 107
Table 35. Spain Nutrigenomics Market by Offering, 2021-2031, $ mn 109
Table 36. Spain Nutrigenomics Market by Application, 2021-2031, $ mn 109
Table 37. Spain Nutrigenomics Market by End User, 2021-2031, $ mn 109
Table 38. Italy Nutrigenomics Market by Offering, 2021-2031, $ mn 111
Table 39. Italy Nutrigenomics Market by Application, 2021-2031, $ mn 111
Table 40. Italy Nutrigenomics Market by End User, 2021-2031, $ mn 111
Table 41. Netherlands Nutrigenomics Market by Offering, 2021-2031, $ mn 113
Table 42. Netherlands Nutrigenomics Market by Application, 2021-2031, $ mn 113
Table 43. Netherlands Nutrigenomics Market by End User, 2021-2031, $ mn 113
Table 44. Nutrigenomics Market in Rest of Europe by Country, 2021-2031, $ mn 115
Table 45. APAC Nutrigenomics Market by Country, 2021-2031, $ mn 118
Table 46. Japan Nutrigenomics Market by Offering, 2021-2031, $ mn 122
Table 47. Japan Nutrigenomics Market by Application, 2021-2031, $ mn 122
Table 48. Japan Nutrigenomics Market by End User, 2021-2031, $ mn 122
Table 49. China Nutrigenomics Market by Offering, 2021-2031, $ mn 124
Table 50. China Nutrigenomics Market by Application, 2021-2031, $ mn 124
Table 51. China Nutrigenomics Market by End User, 2021-2031, $ mn 124
Table 52. Australia Nutrigenomics Market by Offering, 2021-2031, $ mn 126
Table 53. Australia Nutrigenomics Market by Application, 2021-2031, $ mn 126
Table 54. Australia Nutrigenomics Market by End User, 2021-2031, $ mn 126
Table 55. India Nutrigenomics Market by Offering, 2021-2031, $ mn 128
Table 56. India Nutrigenomics Market by Application, 2021-2031, $ mn 128
Table 57. India Nutrigenomics Market by End User, 2021-2031, $ mn 128
Table 58. South Korea Nutrigenomics Market by Offering, 2021-2031, $ mn 130
Table 59. South Korea Nutrigenomics Market by Application, 2021-2031, $ mn 130
Table 60. South Korea Nutrigenomics Market by End User, 2021-2031, $ mn 130
Table 61. Nutrigenomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 132
Table 62. South America Nutrigenomics Market by Country, 2021-2031, $ mn 135
Table 63. Argentina Nutrigenomics Market by Offering, 2021-2031, $ mn 137
Table 64. Argentina Nutrigenomics Market by Application, 2021-2031, $ mn 137
Table 65. Argentina Nutrigenomics Market by End User, 2021-2031, $ mn 137
Table 66. Brazil Nutrigenomics Market by Offering, 2021-2031, $ mn 139
Table 67. Brazil Nutrigenomics Market by Application, 2021-2031, $ mn 139
Table 68. Brazil Nutrigenomics Market by End User, 2021-2031, $ mn 139
Table 69. Chile Nutrigenomics Market by Offering, 2021-2031, $ mn 141
Table 70. Chile Nutrigenomics Market by Application, 2021-2031, $ mn 141
Table 71. Chile Nutrigenomics Market by End User, 2021-2031, $ mn 141
Table 72. MEA Nutrigenomics Market by Country, 2021-2031, $ mn 145
Table 73. UAE Nutrigenomics Market by Offering, 2021-2031, $ mn 147
Table 74. UAE Nutrigenomics Market by Application, 2021-2031, $ mn 147
Table 75. UAE Nutrigenomics Market by End User, 2021-2031, $ mn 147
Table 76. Saudi Arabia Nutrigenomics Market by Offering, 2021-2031, $ mn 149
Table 77. Saudi Arabia Nutrigenomics Market by Application, 2021-2031, $ mn 149
Table 78. Saudi Arabia Nutrigenomics Market by End User, 2021-2031, $ mn 149
Table 79. South Africa Nutrigenomics Market by Offering, 2021-2031, $ mn 151
Table 80. South Africa Nutrigenomics Market by Application, 2021-2031, $ mn 151
Table 81. South Africa Nutrigenomics Market by End User, 2021-2031, $ mn 151
Table 82. Breakdown of World Nutrigenomics Products Market by Key Vendor, 2021, % 155
Table 83. Breakdown of World Nutrigenomics Testing Services Market by Key Vendor, 2021, % 155
Table 84. BASF SE: Company Snapshot 158
Table 85. BASF SE: Business Segmentation 159
Table 86. BASF SE: Product Portfolio 159
